Prolonged-release ketamine tablet has potential as affordable and convenient treatment for severe depression and with minimal side effects

71% of patients found to experience a relapse compared with 43% who received the pills twice a week

More than 85% of women – and more than 300 million people worldwide at any given time – use hormonal contraceptives for at least five years of...

The neurotransmitter dopamine is commonly known for its role in brain networks regulating pleasure and reward. But many people with disorders that...

medlinkAdolescents/medlink who use social media from an early age are more likely to suffer medlinkdepression/medlink, suggests a new study. The

A novel tablet formulation of ketamine has demonstrated potential in the treatment of severe depression, providing a possible substitute for the...

FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free...

AUCKLAND, New Zealand, June 24, 2024. Douglas Pharmaceuticals, New Zealand's largest pharmaceutical company, is pleased to announce that results from...

A new study from the Karolinska Institutet, published in the journal eClinicalMedicine, reveals that GLP-1 agonists, a type of medication used to...